Discover the future of AI drug discovery with Eshwar, winner of the Nebius AI Discovery Award. His team has developed YotaML², the world’s first platform capable of screening a trillion molecules in a wet lab using AI. This breakthrough enables the creation of bespoke binders for elusive targets like GPCRs, ion channels, and transcription factors—revolutionizing treatment for diseases in oncology, neurology, inflammation, and more. by @Ronald_vanLoon & Eswar Iyer | Learn more: https://bit.ly/4leIiG0 Follow my channel today! https://ift.tt/91DYbHX #NebiusAmbassador @nebiusofficial #ai #lifesciences #biotechnology #healthtech #healthcare #medical #medicine #deeplearning #technology #biotechinnovation #futureofmedicine #innovation
from Ronald van Loon https://www.youtube.com/shorts/TRa6u5eBbWU
No comments:
Post a Comment